2024 annual financial data

Corbus Pharmaceuticals Holdings 2024 Net margin

Direct answer

Net margin was Not calculable.

Operating income was -48.72M USD and net income was -40.21M USD.
Operating cash flow was -41.79M USD.

Get free Corbus Pharmaceuticals Holdings email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-48.72M USD
Net income
-40.21M USD
Operating cash flow
-41.79M USD